Anti-Doping Agency (USADA) Mechanistic claims (angiogenesis modulation, nitric oxide pathway, cytoprotection) are preclinical
The long-lasting influence of S protein on cerebrovascular function is unknown and should be investigated in future studies, especially considering the longevity of brain endothelial cells
By addressing inflammation, this therapy may support better overall metabolic regulation
No products are intended for human use.
Pinotti M, Bertolucci C, Frigato E, Branchini A, Cavallari N, Baba K, Contreras-Alcantara S, Ehlen JC, Bernardi F, Paul KN, Tosini G
For prescribers and patients used to seeing copper peptide injectables sold through grey-market suppliers, the regulatory message has not changed: compounding pharmacies cannot legally produce injectable GHK-Cu from bulk substance under 503A